• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX
Click for more information
0.00% 7.8¢

NOXOPHARM LIMITED - Announcements

Market Cap $22.79M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Noxopharm Limited is an Australia-based biotechnology company. The Company is engaged in... Noxopharm Limited is an Australia-based biotechnology company. The Company is engaged in the discovery and development of treatments for cancer and inflammation. The Company has three active drug development programs: its clinical drug candidate Veyonda, plus two technology platforms, Chroma (oncology) and Sofra (inflammation and autoimmunity), which provide the basis for the active development of a growing pipeline of drugs. Veyonda (Idronoxil) is an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers. The Chroma drug candidates have bioactive properties, which it is exploring primarily in the anti-cancer space. Its Sofra platform is centered around short nucleic acid sequences called oligonucleotides, which can act on specific cell receptors to stop inflammation, which is a source of various debilitating and lethal diseases. It is also conducting a dose escalation and dose expansion study of NOX66 in the treatment of COVID-19 infection.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
NOX Noxopharm releases Nyrada Corporate Presentation07/06/18 download Created with Sketch. 1.54MB
NOX Noxopharm Corporate Presentation for Public Briefing07/06/18 download Created with Sketch. 13.14MB
NOX End-of-Study Clinical Data shows benefit of NOX66PRICE SENSITIVE05/06/18 download Created with Sketch. 264.42KB
NOX Noxopharm 2018 Mid-Year Investor Briefings31/05/18 download Created with Sketch. 150.63KB
NOX Section 708 Certificate28/05/18 download Created with Sketch. 233.72KB
NOX Appendix 3B28/05/18 download Created with Sketch. 564.14KB
NOX NOX to present at American Society of Clinical OncologyPRICE SENSITIVE22/05/18 download Created with Sketch. 257.98KB
NOX KZA: Progress Report21/05/18 download Created with Sketch. 147.12KB
NOX Change in substantial holding21/05/18 download Created with Sketch. 167.5KB
NOX Securities to be released from Voluntary Escrow21/05/18 download Created with Sketch. 75.08KB
NOX Section 708 Certificate21/05/18 download Created with Sketch. 232.37KB
NOX Appendix 3B21/05/18 download Created with Sketch. 417.46KB
NOX Noxopharm 2018 Mid-Year Investor Briefings18/05/18 download Created with Sketch. 151.08KB
NOX Results of Meeting15/05/18 download Created with Sketch. 145.58KB
NOX NOX CEO interview updates the company's current R&D program07/05/18 download Created with Sketch. 159.68KB
NOX NOX CEO interview on near complete NOX66 chemotherapy trialPRICE SENSITIVE03/05/18 download Created with Sketch. 159.55KB
NOX NOX CEO interview on Radiotherapy Clinical ProgramsPRICE SENSITIVE27/04/18 download Created with Sketch. 160.78KB
NOX Appendix 4C - quarterlyPRICE SENSITIVE27/04/18 download Created with Sketch. 600.58KB
NOX St Vincent's Hospital study passes first milestonePRICE SENSITIVE17/04/18 download Created with Sketch. 173.47KB
NOX Notice of Extraordinary General Meeting / Proxy Form09/04/18 download Created with Sketch. 1.1MB
NOX Change in substantial holding06/04/18 download Created with Sketch. 162.36KB
NOX Change in substantial holding06/04/18 download Created with Sketch. 208.25KB
NOX DARRT-1 Clinical Study commencesPRICE SENSITIVE05/04/18 download Created with Sketch. 185.93KB
NOX NOX Mid-Year Briefings05/04/18 download Created with Sketch. 231.79KB
NOX Section 708 Certificate29/03/18 download Created with Sketch. 233.75KB
NOX Appendix 3B29/03/18 download Created with Sketch. 561.16KB
NOX NOX raises $10.8 M to advance clinical programPRICE SENSITIVE23/03/18 download Created with Sketch. 156.69KB
NOX Trading HaltPRICE SENSITIVE21/03/18 download Created with Sketch. 446.67KB
NOX Evidence of Abscopal Responses in PatientsPRICE SENSITIVE21/03/18 download Created with Sketch. 259.79KB
NOX Corporate Presentation - Post Interim Clinical Data Release12/03/18 download Created with Sketch. 11.08MB
NOX FNN Interview with Noxopharm CEO09/03/18 download Created with Sketch. 170.86KB
NOX NOX Reports NOX66 Clinical DataPRICE SENSITIVE06/03/18 download Created with Sketch. 478.49KB
NOX Trading HaltPRICE SENSITIVE05/03/18 download Created with Sketch. 448.29KB
NOX Update accompanying Half Year Report23/02/18 download Created with Sketch. 254.23KB
NOX Appendix 4D and Half Year AccountsPRICE SENSITIVE23/02/18 download Created with Sketch. 3.34MB
NOX NOX closes $4m capital raising for US subsidiary Nyrada IncPRICE SENSITIVE16/02/18 download Created with Sketch. 475.89KB
NOX Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 524.03KB
NOX Section 708 Certificate25/01/18 download Created with Sketch. 234.14KB
NOX Appendix 3B25/01/18 download Created with Sketch. 563.9KB
NOX KZA: Receipt of securities in Noxopharm Limited (NOX)22/01/18 download Created with Sketch. 397.86KB
NOX Section 708 Certificate18/01/18 download Created with Sketch. 233.6KB
NOX Appendix 3B18/01/18 download Created with Sketch. 564.67KB
NOX NOX receives FY17 R&D Tax RebatePRICE SENSITIVE17/01/18 download Created with Sketch. 333.11KB
NOX Kazia Therapeutics Ltd and Noxopharm Ltd27/12/17 download Created with Sketch. 383.39KB
NOX KZA: Kazia Therapeutics and NoxopharmPRICE SENSITIVE27/12/17 download Created with Sketch. 383.57KB
NOX EOY Guidance on 2018 NOX66 Clinical Development StrategyPRICE SENSITIVE21/12/17 download Created with Sketch. 348.01KB
NOX Section 708 Certificate19/12/17 download Created with Sketch. 234.33KB
NOX Appendix 3B19/12/17 download Created with Sketch. 563.3KB
NOX Response to ASX Price QueryPRICE SENSITIVE14/12/17 download Created with Sketch. 633.44KB
NOX Appendix 3B12/12/17 download Created with Sketch. 563.89KB
NOX Change of Registered Office11/12/17 download Created with Sketch. 231.47KB
NOX Section 708 Certificate07/12/17 download Created with Sketch. 235.68KB
NOX Appendix 3B07/12/17 download Created with Sketch. 563.67KB
NOX NOX Open Briefing Corporate Presentation06/12/17 download Created with Sketch. 9MB
NOX Compassionate use of NOX66 in Patients04/12/17 download Created with Sketch. 249.55KB
NOX Nyrada Inc Opens Capital Raise - Memorandum ReleasedPRICE SENSITIVE01/12/17 download Created with Sketch. 684.8KB
NOX Change of Director's Interest Notice - PM29/11/17 download Created with Sketch. 232.3KB
NOX Change of Director's Interest Notice - ID29/11/17 download Created with Sketch. 232.69KB
NOX Appendix 3B29/11/17 download Created with Sketch. 561.94KB
NOX Webcast of NOX 2017 AGM29/11/17 download Created with Sketch. 232.87KB
NOX NYX-104 delivers Key Proof-of-Concept in Stroke Animal ModelPRICE SENSITIVE29/11/17 download Created with Sketch. 559.5KB
NOX Invitation to Open Briefing28/11/17 download Created with Sketch. 247.09KB
NOX Results of Meeting27/11/17 download Created with Sketch. 248.29KB
NOX AGM Presentations27/11/17 download Created with Sketch. 12.39MB
NOX Clarification of Incorrect InformationPRICE SENSITIVE23/11/17 download Created with Sketch. 377KB
NOX Trading HaltPRICE SENSITIVE23/11/17 download Created with Sketch. 448.63KB
NOX NRT: Kazia clarifies media report22/11/17 download Created with Sketch. 531.52KB
NOX NOX 2017 AGM Webcast21/11/17 download Created with Sketch. 262.05KB
NOX Completion of Transfer of Shares to Nyrada Inc21/11/17 download Created with Sketch. 234.89KB
NOX Promising Interim Clinical Data for NOX66PRICE SENSITIVE20/11/17 download Created with Sketch. 1.18MB
NOX Trading HaltPRICE SENSITIVE17/11/17 download Created with Sketch. 448.39KB
NOX 1st Patient treated in Lupin Study at St Vincent's HospitalPRICE SENSITIVE16/11/17 download Created with Sketch. 376.48KB
NOX Section 708 Certificate15/11/17 download Created with Sketch. 235.43KB
NOX Appendix 3B15/11/17 download Created with Sketch. 508.89KB
NOX NOX making three presentations at COSA13/11/17 download Created with Sketch. 464.3KB
NOX Section 708 Certificate07/11/17 download Created with Sketch. 235.41KB
NOX Appendix 3B07/11/17 download Created with Sketch. 508.18KB
NOX Results of Meeting06/11/17 download Created with Sketch. 364.07KB
NOX EGM Presentations06/11/17 download Created with Sketch. 7.8MB
NOX UNSW collaboration confirms drug designed for stroke victimsPRICE SENSITIVE03/11/17 download Created with Sketch. 338.88KB
NOX Appendix 4C - quarterlyPRICE SENSITIVE30/10/17 download Created with Sketch. 602.38KB
NOX Notice of Annual General Meeting/Proxy Form26/10/17 download Created with Sketch. 1.3MB
NOX Annual Report to shareholders26/10/17 download Created with Sketch. 1.02MB
NOX Corporate Governance Statement - Appendix 4G26/10/17 download Created with Sketch. 259.24KB
NOX Corporate Governance Statement - 201726/10/17 download Created with Sketch. 484.88KB
NOX Update - General Meeting Agenda23/10/17 download Created with Sketch. 316KB
NOX October 2017 Open Briefing Corporate Presentation19/10/17 download Created with Sketch. 10.35MB
NOX Invitation to Open Briefing13/10/17 download Created with Sketch. 247.6KB
NOX Establishment of Nyrada Inc. - Extraordinary General Meeting04/10/17 download Created with Sketch. 1.61MB
NOX Australian NOX66 - Radiotherapy Study OpensPRICE SENSITIVE27/09/17 download Created with Sketch. 406.98KB
NOX Establishment of Nyrada Inc.PRICE SENSITIVE25/09/17 download Created with Sketch. 475.61KB
NOX Positive Clinical Outcomes for NOX66 at ESMO ConferencePRICE SENSITIVE12/09/17 download Created with Sketch. 258.19KB
NOX Change in substantial holding07/09/17 download Created with Sketch. 152.29KB
NOX Change in substantial holding06/09/17 download Created with Sketch. 148.75KB
NOX Placement completed App 3B, s708 Notice, LR7.1A4(b) Notice04/09/17 download Created with Sketch. 967.73KB
NOX NOX CEO Interview explains recent Brain Cancer Announcement04/09/17 download Created with Sketch. 236.11KB
NOX Appendix 4E and Audited Financial StatementsPRICE SENSITIVE31/08/17 download Created with Sketch. 8.68MB
NOX Corporate Governance Statement - Appendix 4G31/08/17 download Created with Sketch. 487.94KB
NOX Corporate Governance Statement31/08/17 download Created with Sketch. 484.88KB
NOX Important Brain Cancer Findings for NOX66 ProgramPRICE SENSITIVE29/08/17 download Created with Sketch. 259.63KB
NOX Noxopharm releases Nyrada Corporate Presentation
07/06/18 download Created with Sketch. 1.54MB
NOX Noxopharm Corporate Presentation for Public Briefing
07/06/18 download Created with Sketch. 13.14MB
NOX End-of-Study Clinical Data shows benefit of NOX66
05/06/18PRICE SENSITIVE download Created with Sketch. 264.42KB
NOX Noxopharm 2018 Mid-Year Investor Briefings
31/05/18 download Created with Sketch. 150.63KB
NOX Section 708 Certificate
28/05/18 download Created with Sketch. 233.72KB
NOX Appendix 3B
28/05/18 download Created with Sketch. 564.14KB
NOX NOX to present at American Society of Clinical Oncology
22/05/18PRICE SENSITIVE download Created with Sketch. 257.98KB
NOX KZA: Progress Report
21/05/18 download Created with Sketch. 147.12KB
NOX Change in substantial holding
21/05/18 download Created with Sketch. 167.5KB
NOX Securities to be released from Voluntary Escrow
21/05/18 download Created with Sketch. 75.08KB
NOX Section 708 Certificate
21/05/18 download Created with Sketch. 232.37KB
NOX Appendix 3B
21/05/18 download Created with Sketch. 417.46KB
NOX Noxopharm 2018 Mid-Year Investor Briefings
18/05/18 download Created with Sketch. 151.08KB
NOX Results of Meeting
15/05/18 download Created with Sketch. 145.58KB
NOX NOX CEO interview updates the company's current R&D program
07/05/18 download Created with Sketch. 159.68KB
NOX NOX CEO interview on near complete NOX66 chemotherapy trial
03/05/18PRICE SENSITIVE download Created with Sketch. 159.55KB
NOX NOX CEO interview on Radiotherapy Clinical Programs
27/04/18PRICE SENSITIVE download Created with Sketch. 160.78KB
NOX Appendix 4C - quarterly
27/04/18PRICE SENSITIVE download Created with Sketch. 600.58KB
NOX St Vincent's Hospital study passes first milestone
17/04/18PRICE SENSITIVE download Created with Sketch. 173.47KB
NOX Notice of Extraordinary General Meeting / Proxy Form
09/04/18 download Created with Sketch. 1.1MB
NOX Change in substantial holding
06/04/18 download Created with Sketch. 162.36KB
NOX Change in substantial holding
06/04/18 download Created with Sketch. 208.25KB
NOX DARRT-1 Clinical Study commences
05/04/18PRICE SENSITIVE download Created with Sketch. 185.93KB
NOX NOX Mid-Year Briefings
05/04/18 download Created with Sketch. 231.79KB
NOX Section 708 Certificate
29/03/18 download Created with Sketch. 233.75KB
NOX Appendix 3B
29/03/18 download Created with Sketch. 561.16KB
NOX NOX raises $10.8 M to advance clinical program
23/03/18PRICE SENSITIVE download Created with Sketch. 156.69KB
NOX Trading Halt
21/03/18PRICE SENSITIVE download Created with Sketch. 446.67KB
NOX Evidence of Abscopal Responses in Patients
21/03/18PRICE SENSITIVE download Created with Sketch. 259.79KB
NOX Corporate Presentation - Post Interim Clinical Data Release
12/03/18 download Created with Sketch. 11.08MB
NOX FNN Interview with Noxopharm CEO
09/03/18 download Created with Sketch. 170.86KB
NOX NOX Reports NOX66 Clinical Data
06/03/18PRICE SENSITIVE download Created with Sketch. 478.49KB
NOX Trading Halt
05/03/18PRICE SENSITIVE download Created with Sketch. 448.29KB
NOX Update accompanying Half Year Report
23/02/18 download Created with Sketch. 254.23KB
NOX Appendix 4D and Half Year Accounts
23/02/18PRICE SENSITIVE download Created with Sketch. 3.34MB
NOX NOX closes $4m capital raising for US subsidiary Nyrada Inc
16/02/18PRICE SENSITIVE download Created with Sketch. 475.89KB
NOX Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 524.03KB
NOX Section 708 Certificate
25/01/18 download Created with Sketch. 234.14KB
NOX Appendix 3B
25/01/18 download Created with Sketch. 563.9KB
NOX KZA: Receipt of securities in Noxopharm Limited (NOX)
22/01/18 download Created with Sketch. 397.86KB
NOX Section 708 Certificate
18/01/18 download Created with Sketch. 233.6KB
NOX Appendix 3B
18/01/18 download Created with Sketch. 564.67KB
NOX NOX receives FY17 R&D Tax Rebate
17/01/18PRICE SENSITIVE download Created with Sketch. 333.11KB
NOX Kazia Therapeutics Ltd and Noxopharm Ltd
27/12/17 download Created with Sketch. 383.39KB
NOX KZA: Kazia Therapeutics and Noxopharm
27/12/17PRICE SENSITIVE download Created with Sketch. 383.57KB
NOX EOY Guidance on 2018 NOX66 Clinical Development Strategy
21/12/17PRICE SENSITIVE download Created with Sketch. 348.01KB
NOX Section 708 Certificate
19/12/17 download Created with Sketch. 234.33KB
NOX Appendix 3B
19/12/17 download Created with Sketch. 563.3KB
NOX Response to ASX Price Query
14/12/17PRICE SENSITIVE download Created with Sketch. 633.44KB
NOX Appendix 3B
12/12/17 download Created with Sketch. 563.89KB
NOX Change of Registered Office
11/12/17 download Created with Sketch. 231.47KB
NOX Section 708 Certificate
07/12/17 download Created with Sketch. 235.68KB
NOX Appendix 3B
07/12/17 download Created with Sketch. 563.67KB
NOX NOX Open Briefing Corporate Presentation
06/12/17 download Created with Sketch. 9MB
NOX Compassionate use of NOX66 in Patients
04/12/17 download Created with Sketch. 249.55KB
NOX Nyrada Inc Opens Capital Raise - Memorandum Released
01/12/17PRICE SENSITIVE download Created with Sketch. 684.8KB
NOX Change of Director's Interest Notice - PM
29/11/17 download Created with Sketch. 232.3KB
NOX Change of Director's Interest Notice - ID
29/11/17 download Created with Sketch. 232.69KB
NOX Appendix 3B
29/11/17 download Created with Sketch. 561.94KB
NOX Webcast of NOX 2017 AGM
29/11/17 download Created with Sketch. 232.87KB
NOX NYX-104 delivers Key Proof-of-Concept in Stroke Animal Model
29/11/17PRICE SENSITIVE download Created with Sketch. 559.5KB
NOX Invitation to Open Briefing
28/11/17 download Created with Sketch. 247.09KB
NOX Results of Meeting
27/11/17 download Created with Sketch. 248.29KB
NOX AGM Presentations
27/11/17 download Created with Sketch. 12.39MB
NOX Clarification of Incorrect Information
23/11/17PRICE SENSITIVE download Created with Sketch. 377KB
NOX Trading Halt
23/11/17PRICE SENSITIVE download Created with Sketch. 448.63KB
NOX NRT: Kazia clarifies media report
22/11/17 download Created with Sketch. 531.52KB
NOX NOX 2017 AGM Webcast
21/11/17 download Created with Sketch. 262.05KB
NOX Completion of Transfer of Shares to Nyrada Inc
21/11/17 download Created with Sketch. 234.89KB
NOX Promising Interim Clinical Data for NOX66
20/11/17PRICE SENSITIVE download Created with Sketch. 1.18MB
NOX Trading Halt
17/11/17PRICE SENSITIVE download Created with Sketch. 448.39KB
NOX 1st Patient treated in Lupin Study at St Vincent's Hospital
16/11/17PRICE SENSITIVE download Created with Sketch. 376.48KB
NOX Section 708 Certificate
15/11/17 download Created with Sketch. 235.43KB
NOX Appendix 3B
15/11/17 download Created with Sketch. 508.89KB
NOX NOX making three presentations at COSA
13/11/17 download Created with Sketch. 464.3KB
NOX Section 708 Certificate
07/11/17 download Created with Sketch. 235.41KB
NOX Appendix 3B
07/11/17 download Created with Sketch. 508.18KB
NOX Results of Meeting
06/11/17 download Created with Sketch. 364.07KB
NOX EGM Presentations
06/11/17 download Created with Sketch. 7.8MB
NOX UNSW collaboration confirms drug designed for stroke victims
03/11/17PRICE SENSITIVE download Created with Sketch. 338.88KB
NOX Appendix 4C - quarterly
30/10/17PRICE SENSITIVE download Created with Sketch. 602.38KB
NOX Notice of Annual General Meeting/Proxy Form
26/10/17 download Created with Sketch. 1.3MB
NOX Annual Report to shareholders
26/10/17 download Created with Sketch. 1.02MB
NOX Corporate Governance Statement - Appendix 4G
26/10/17 download Created with Sketch. 259.24KB
NOX Corporate Governance Statement - 2017
26/10/17 download Created with Sketch. 484.88KB
NOX Update - General Meeting Agenda
23/10/17 download Created with Sketch. 316KB
NOX October 2017 Open Briefing Corporate Presentation
19/10/17 download Created with Sketch. 10.35MB
NOX Invitation to Open Briefing
13/10/17 download Created with Sketch. 247.6KB
NOX Establishment of Nyrada Inc. - Extraordinary General Meeting
04/10/17 download Created with Sketch. 1.61MB
NOX Australian NOX66 - Radiotherapy Study Opens
27/09/17PRICE SENSITIVE download Created with Sketch. 406.98KB
NOX Establishment of Nyrada Inc.
25/09/17PRICE SENSITIVE download Created with Sketch. 475.61KB
NOX Positive Clinical Outcomes for NOX66 at ESMO Conference
12/09/17PRICE SENSITIVE download Created with Sketch. 258.19KB
NOX Change in substantial holding
07/09/17 download Created with Sketch. 152.29KB
NOX Change in substantial holding
06/09/17 download Created with Sketch. 148.75KB
NOX Placement completed App 3B, s708 Notice, LR7.1A4(b) Notice
04/09/17 download Created with Sketch. 967.73KB
NOX NOX CEO Interview explains recent Brain Cancer Announcement
04/09/17 download Created with Sketch. 236.11KB
NOX Appendix 4E and Audited Financial Statements
31/08/17PRICE SENSITIVE download Created with Sketch. 8.68MB
NOX Corporate Governance Statement - Appendix 4G
31/08/17 download Created with Sketch. 487.94KB
NOX Corporate Governance Statement
31/08/17 download Created with Sketch. 484.88KB
NOX Important Brain Cancer Findings for NOX66 Program
29/08/17PRICE SENSITIVE download Created with Sketch. 259.63KB
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
7.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $22.79M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 66329 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 95848 2
View Market Depth
Last trade - 13.49pm 16/05/2024 (20 minute delay) ?
NOX (ASX) Chart

Top Stories

Miramar upgrades target within WA's Gidji, suggests extension to Northern Star's 8 Mile Dam

Miramar Resources Ltd has updated its 8-Mile target within the Gidji project in WA based on recent reprocessing of data.
The home PC changed retail stores forever. Shekel Brainweigh can do it again Retail store automation demands tech to prevent shoplifting and give business owners peace of mind. Shekel Brainweigh does just that.
After long delays, Mantle Minerals kicks off drillrun for gold at Mt Berghaus After delays borne from tenement disputes with rail operators, Mantle Minerals has kicked off drilling at its Mt. Berghaus tenements in WA.
Greentech and Anax team up to put Whim Creek copper hub on steroids GreenTech Metals and Anax Metals are set to sign a memorandum of understanding to strategise processing and development of key copper assets.
Market Update: ASX accelerates ahead of future forecasts The ASX200 delivered a sweet surprise this morning, surging 1.7 per cent to deliver growth far in excess of future’s predictions.Every sector @ aside from energy @ is in the green mid-session. IT and real estate are the top gainers @ both are up more than 3%.The Australian unemplo...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.